目的 观察一种新型人甲状旁腺素相关肽（ 8L -hPTH ）对去卵巢大鼠骨质疏松的治疗作用。 方法 88 只 3 月龄 SD 健康雌性大鼠其中 64 只行双侧卵巢摘除术 16 只做假手术。 3 个月后各取 8 只测定腰椎及股骨骨密度。将余下的 56 只卵巢摘除大鼠随机分为 7 组每组 8 只，分别为 8L -hPTH 高、中、低剂量治疗组 ( 剂量分别为 20 ， 10 ， 5 μg·kg-1·d-1) ； hPTH(1-34) 高、中、低剂量对照组 ( 剂量分别为 20 ， 10 ， 5 μg·kg-1·d-1) ；生理盐水组（ 0.5 mL·d-1 ），各组均为皮下注射。假手术组余下的 8 只以及剩余 8 只未做任何手术的大鼠，给药方式及剂量均同生 理盐水组。连续给药 3 个月后，比较各组大鼠股骨、腰椎骨密度并用扫描电镜观察股骨情况。 结果 双侧卵巢摘除 3 个月后，大鼠腰椎及股骨骨密度均明显低于假手术组 ( P<0.01) ，说明造模成功。给药 3 月后， 8L -hPTH 各治疗组大鼠与生理盐水组相比较，股骨、腰椎骨密度均显著升高 ( P<0.05) ，骨小梁宽度有极显著增加 ( P<0.001) ，效果呈剂量依赖性。 结论 皮下注射 8L -hPTH(5~20 μg·kg-1·d-1) 对去卵巢骨质疏松大鼠有明显的治疗作用。
Abstract
OBJECTIVE To evaluate the therapeutic effect of a novel recombinant human parathyroid hormone related-peptide on ovariectomized rats. METHODS Sixty-four of 88 3-month-old female Sprague-Dawley rats were ovariectomized and 16 received sham operation.Three months later, 8 rats from each group received bone material density (BMD) test. Then the remaining 56 ovariectomized rats were randomly assigned to 7 groups: control group (NS, 0.5 mL normal saline), 8L-hPTH groups (20, 10, 5 μg·kg-1), hPTH(1-34) groups (20, 10, 5 μg·kg-1). Another 8 rats without any operation and sham-operated rats (sham) were treated in the same way as those of group NS. All rats were subcutaneously injected in consecutive days for 3 months. The femoral and lumbar BMD were measured and the femurs were observed by scanning electron microscope after 3-month-therapy. RESULTS Three months later, the femoral and lumbar BMD of ovariectomized rats were significantly decreased, compared with those of sham-operated rats (P<0.01). Furthermore, the femoral and lumbar BMD and trabecular widths of 8L-hPTH therapeutic groups were all increased obviously compared with those of group NS (P<0.05 and P<0.01). CONCLUSION 8L-hPTH is effective in stimulating bone formation and improving skeletal microarchitecture. 8L-hPTH is potentially a effective therapeutical agent on osteoporosis.
关键词
人甲状旁腺素 /
卵巢切除术 /
骨质疏松症 /
骨密度 /
骨小梁
{{custom_keyword}} /
Key words
human parathyroid hormone /
ovariectomy /
osteoporosis /
bone material densities /
trabecula of bone
{{custom_keyword}} /
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] ROSEN C J. What’s new with PTH in osteoporosis where are we and where are we headed? [J]. <>Trends Endocrinol Metab, 2004,15(5):229-233.
[2] WANG C X, LIU J J . The relationship of the structures and functions of hPTH(1-34) and hPTHrP(1-34) [J]. <>Pharm Biotechnol ( 药物生物技术 ), 2003, 10(6):394-400.
[3] ROSEN C J, BILEZIKIAN J P. Anabolic therapy for osteoporosis [J]. <>J Clin <> Endocrinology <> Metab , 2001, 86(3): 957-964 .
[4] COSMAN F, NIEVES J, WOELFERT L, et al. Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal[J]. <>J Bone Miner Res, 2001, 16(5): 925-931.
[5] NEER R M, ARNAUD C D, ARNAUD , et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis[J]. <>N Engl <> J Med, 2001,344(19):1434-1441.
[6] GOLTZMAN D. Interactions of PTH and PTHrp with the PTH/PTHrp receptor and downstream signaling pathways: exceptions that provide the rules[J]. <>J Bone Miner Res, 1999, 14(2):173-177.
[7] HOCK J M, GERAL I, FONESCA J, <>et a1. Human parathyroid hormone (1-34). Increases bone mass in ovariectomized and orchidectomized rats [J]. <>Endocrinol, 1998, 122(6):2899-2904.
[8] DEMPSTER D W,COSMAN F,KURLAND E S, <>et al. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis:a paired biopsy study[J]. <>J Bone Miner Res,2001,16(10):1846-1853.
[9] WRENGER S, KAHNE T, BOHUON C, <>et al. Amino-terminal truncation of procalcitonin, a marker for systemic bacterial infections, by dipeptidyl peptidase Ⅳ (DPⅣ) [J]. <>FEBS Lett, 2000, 466 (1): 155-159.
[10] JIN L, BRIGGS S L, CHANDRASEHAR S, <>et al. Crystal structure of human parathyroid hormone 1-34 at 0.9-resolution [J]. <>J Biol Chem, 2000,275(35): 27238-27244.
[11] SHI X M, WANG C X, ZHUANG Z H, <>et al. Preparation of a novel recombinant human parathyroid hormone and investigation of its nasal drops[J]. <>J Southeast Univ (<>Med Sci Ed)( 东南大学学报：医学版 ), 2008, 27(1):31-36.
（ 收稿日期 ： 2008-12-24 ）
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
PDF(3057 KB)
